Oxford University has a special responsibility to ensure jabs reach the Global South
McDonagh, L.
(28 April 2021)
Oxford University has a special responsibility to ensure jabs reach the Global South.
LSE COVID-19 Blog.
Oxford University stands to make many millions from its vaccine spin-out. Yet the deals it has done, and the lack of a patent waiver, limit the ability of the Global South to manufacture AstraZeneca jabs. Luke McDonagh (LSE) argues that the university, as a wealthy and publicly funded institution, has a special responsibility to ensure the vaccine reaches countries where thousands of people are dying from COVID every day.
| Item Type | Blog post |
|---|---|
| Copyright holders | © 2021 The Author |
| Departments | LSE > Academic Departments > Law School |
| Date Deposited | 25 May 2021 |
| URI | https://researchonline.lse.ac.uk/id/eprint/110580 |
ORCID: https://orcid.org/0000-0003-2085-5404